bitcoin
Bitcoin (BTC) $ 76,278.44
ethereum
Ethereum (ETH) $ 2,924.90
tether
Tether (USDT) $ 1.00
bnb
BNB (BNB) $ 606.43
usd-coin
USDC (USDC) $ 1.00
xrp
XRP (XRP) $ 0.557372
binance-usd
BUSD (BUSD) $ 1.00
dogecoin
Dogecoin (DOGE) $ 0.195367
cardano
Cardano (ADA) $ 0.417792
solana
Solana (SOL) $ 200.09
matic-network
Polygon (MATIC) $ 0.348704
polkadot
Polkadot (DOT) $ 4.20
tron
TRON (TRX) $ 0.160909
bitcoin
Bitcoin (BTC) $ 76,278.44
ethereum
Ethereum (ETH) $ 2,924.90
tether
Tether (USDT) $ 1.00
bnb
BNB (BNB) $ 606.43
usd-coin
USDC (USDC) $ 1.00
xrp
XRP (XRP) $ 0.557372
binance-usd
BUSD (BUSD) $ 1.00
dogecoin
Dogecoin (DOGE) $ 0.195367
cardano
Cardano (ADA) $ 0.417792
solana
Solana (SOL) $ 200.09
matic-network
Polygon (MATIC) $ 0.348704
polkadot
Polkadot (DOT) $ 4.20
tron
TRON (TRX) $ 0.160909
More

    Sq. Enix proclaims public sale dates for Symbiogenesis NFTs

    Latest News

    Closing Fantasy sport developer Sq. Enix introduced public sale dates for its upcoming Symbiogenesis non-fungible tokens (NFTs). In a Nov. 24 social media submit, the crew mentioned it will promote the NFTs in three batches. The primary batch can be auctioned from Nov. 27-28, the second from Nov. 30-Dec. 4 and the third from Dec. 2 to Dec. 3. Symbiogenesis is Sq. Enix’s upcoming blockchain sport that options Ethereum-based NFTs.

    In keeping with the sport’s paperwork, the primary section will embody aspect and mesh characters and can solely enable “stakeholders” to take part. This appears to indicate that solely early traders will have the ability to take part within the Novemb 27-28 section. The second and third phases will be out there to individuals in an “allowlist entry marketing campaign,” the paperwork state.

    Symbiogenesis sport world, as proven on its homepage. Supply: Sq. Enix.

    Proceed Studying on Cointelegraph

    See also  Shares fall, yields rise as inflation knowledge is available in hotter than anticipated

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Hot Topics

    Related Articles